Berry Genomics
Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
Berry Genomics, founded in May, 2010 and headquartered in Chengdu, is a gene sequencing in the field of clinical translation company. The founder is Gao Yang. Listed on the SZSE on April 22, 1997, the company's major shareholders are Gao Yang, Chengdu Tianxing Instrument and Meter Co.,Ltd. and Tianjin Junruiqi Equity Investment Partnership (LP). Rivals that have direct and indirect competition with Berry Genomics include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
AI Pharmaceutical R&D Company DP Technology Raises New Round of Over CNY 700 Mn Financing
EqualOcean has learned that DP Technology(深势科技), an AI pharmaceutical research company, has recently successfully completed a funding round of over CNY 700 million. Investors in this round include Zhongyuan Capital(众源资本), MSA Capital(和玉资本), Loyal Valley Capital(正心谷资本), Evergreen Scitech Delta(深势科技), and many other industry-specific investors, with Lighthouse Capital(光源资本) serving as the exclusive financial advisor.
Aug 22, 2023 03:34 PM